Neurocrine Biosciences to Host Conference Call and Webcast for Second Quarter 2025 Financial Results
SAN DIEGO, CA – July 9, 2025 – Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that it will host a conference call and webcast to discuss its financial results for the second quarter ended June 30, 2025. The event is scheduled to take place on Tuesday, July 29, 2025, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
This conference call provides an important opportunity for investors and interested parties to gain insights into Neurocrine Biosciences’ performance during the second quarter of 2025. The company is expected to share key financial metrics, including revenue, earnings, and any significant business updates.
During the call, management will provide an overview of the company’s operational highlights, pipeline advancements, and strategic priorities. This will likely include discussions on the commercial performance of their approved products and progress in their research and development programs, which are focused on treating neurological and endocrine-related diseases.
Following the prepared remarks, there will be a question-and-answer session where participants can directly engage with the Neurocrine Biosciences leadership team. This segment often offers valuable context and further details on the company’s outlook and strategies.
The conference call can be accessed by dialing 877-407-0792 (domestic) or 201-689-8457 (international). A live webcast of the call will also be available on the Investor Relations section of the Neurocrine Biosciences website at www.neurocrine.com.
For those unable to listen to the live broadcast, a replay of the conference call will be archived on the company’s website for a period of time following the event. This ensures that all interested stakeholders have the opportunity to review the information shared.
Neurocrine Biosciences, a leading neuroscience-focused, biopharmaceutical company, continues to be dedicated to discovering, developing, and commercializing innovative therapies for patients suffering from underserved neurological and endocrine diseases. The upcoming conference call will offer a comprehensive update on their journey and achievements.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results’ at 2025-07-09 20:01. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.